Telehealth technology can help recruit, retain and engage more diverse participants in clinical trials. This panel will discuss diversity in recruitment, what has worked, and what else needs to be addressed to have a better mix of participants who fully reflect populations who would benefit from the therapies being researched.
Tufia C. Haddad, MD, Chair of Practice Innovation and Platform, Mayo Clinic
Gilles Lunzenfichter, CEO, Medisanté Group AG
Warren Smedley, Vice President, the Kinetix Group
Reginald Swift PhD, Founder/CEO, Rubix LS
Moderated by: Vera Rulon, Founder and President, Tir Health Advisors LLC
This event is hosted by the ATA's Decentralized Clinical Trial Special Interest Group.